Stocks
Dolby Laboratories Financial Statements (DLB) |
||||||||||
| Dolby Laboratoriessmart-lab.ru | % | 2023Q2 | 2023Q2 | 2023Q2 | 2023Q3 | 2023Q4 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 02.02.2023 | 04.05.2023 | 05.05.2023 | 03.08.2023 | 17.11.2023 | 17.11.2023 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 334.9 | 375 891 | 375.9 | 298.4 | 290.6 | 376 856 | |||
| Operating Income, bln rub | 94.1 | 74 332 | 84.7 | 15.9 | -3.49 | 74 429 | ||||
| EBITDA, bln rub | ? | 122.2 | 109 224 | 109.3 | 64.9 | 82.0 | 109 480 | |||
| Net profit, bln rub | ? | 79.4 | 138 679 | 95.7 | 16.4 | 9.19 | 138 800 | |||
| OCF, bln rub | ? | 56.4 | 104.5 | 121.1 | 85.0 | 310.7 | ||||
| CAPEX, bln rub | ? | 7.22 | 7.52 | 7.41 | 8.19 | 23.1 | ||||
| FCF, bln rub | ? | 49.2 | 97.0 | 113.7 | 76.8 | 287.6 | ||||
| Dividend payout, bln rub | 25.9 | 25.9 | 25.8 | 25.8 | 77.5 | |||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 32.6% | 0.00% | 27.0% | 157.6% | 281.1% | 0.06% | ||||
| OPEX, bln rub | 206.6 | 225 585 | 225.6 | 224.2 | 227.9 | 226 263 | ||||
| Cost of production, bln rub | 34.5 | 41 049 | 41.0 | 41.5 | 35.6 | 41 167 | ||||
| R&D, bln rub | 64.5 | 67 951 | 68.0 | 68.7 | 70.4 | 68 158 | ||||
| Interest expenses, bln rub | 0.081 | 34.0 | 34.0 | 0.114 | 0.000 | 68.1 | ||||
| Assets, bln rub | 2 749 | 2 836 133 | 2 836 | 3 008 | 2 980 | 2 980 | ||||
| Net Assets, bln rub | ? | 2 288 | 2 350 784 | 2 351 | 2 366 | 2 355 | 2 355 | |||
| Debt, bln rub | 47.4 | 47 868 | 47.9 | 50.1 | 50.6 | 50.6 | ||||
| Cash, bln rub | 759.0 | 814 836 | 814.8 | 889.3 | 884.5 | 884.5 | ||||
| Net debt, bln rub | -711.6 | -766 968 | -767.0 | -839.2 | -833.9 | -833.9 | ||||
| Ordinary share price, rub | 70.5 | 85.4 | 85.4 | 83.7 | 79.3 | 83.5 | ||||
| Number of ordinary shares, mln | 95.9 | 95 820 | 95.8 | 95.7 | 95.7 | 95.7 | ||||
| Market cap, bln rub | 6 765 | 8 184 944 | 8 185 | 8 005 | 7 585 | 7 986 | ||||
| EV, bln rub | ? | 6 054 | 7 417 976 | 7 418 | 7 165 | 6 751 | 7 152 | |||
| Book value, bln rub | 1 812 | 2 350 784 | 1 882 | 1 763 | 1 779 | 1 779 | ||||
| EPS, rub | ? | 0.83 | 1.45 | 1.00 | 0.17 | 0.10 | 1 450 | |||
| FCF/share, rub | 0.51 | 0.00 | 1.01 | 1.19 | 0.80 | 3.00 | ||||
| BV/share, rub | 18.9 | 24.5 | 19.6 | 18.4 | 18.6 | 18.6 | ||||
| EBITDA margin, % | ? | 36.5% | 29.1% | 29.1% | 21.7% | 28.2% | 29.1% | |||
| Net margin, % | ? | 23.7% | 36.9% | 25.5% | 5.50% | 3.16% | 36.8% | |||
| FCF yield, % | ? | 2.78% | 0.00% | 3.48% | 3.86% | 5.09% | 3.60% | |||
| ROE, % | ? | 11.6% | 5.91% | 15.4% | 11.4% | 11.9% | 5 894% | |||
| ROA, % | ? | 9.68% | 4.90% | 12.8% | 9.00% | 9.40% | 4 658% | |||
| P/E | ? | 25.4 | 58.9 | 22.6 | 29.6 | 27.1 | 0.06 | |||
| P/FCF | 137.6 | 28.7 | 25.9 | 19.7 | 27.8 | |||||
| P/S | ? | 5.27 | 21.7 | 4.93 | 5.96 | 4.64 | 0.02 | |||
| P/BV | ? | 3.73 | 3.48 | 4.35 | 4.54 | 4.26 | 4.49 | |||
| EV/EBITDA | ? | 14.4 | 67.7 | 14.5 | 17.1 | 13.5 | 0.07 | |||
| Debt/EBITDA | -1.69 | -7.00 | -1.50 | -2.01 | -1.67 | -0.01 | ||||
| R&D/CAPEX, % | 893.0% | 903.1% | 926.7% | 860.4% | 294 776% | |||||
| CAPEX/Revenue, % | 2.15% | 0.00% | 2.00% | 2.48% | 2.82% | 0.01% | ||||
| Dolby Laboratories shareholders | ||||||||||
